Literature DB >> 2210803

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

M Dohlsten1, P A Lando, G Hedlund, J Trowsdale, T Kalland.   

Abstract

The staphylococcal enterotoxins (SE) comprise a family of structurally related phage-encoded bacterial proteins, which are the most potent mitogens known for murine and human T lymphocytes. In this report we describe a novel cytotoxic mechanism, where SE directs human CD3+ T lymphocytes to mediate strong cytotoxicity against target cells of irrelevant nominal specificity. The SE-dependent cellular cytotoxicity (SDCC) occurred at picomolar concentrations of SE and involved the initial binding of the SE to the target cells and subsequent triggering of the cytotoxic T cells. SDCC was induced by SEA, SEB, SEC1 and SED, which indicates that this is a common property conserved among all SE. Certain antibodies to the HLA-DR molecule efficiently blocked SDCC. Major histocompatibility complex (MHC) class II+ RAJI cells and HLA-DR-transfected murine L cells were sensitive to SDCC, whereas the MHC class II- RJ.2.2.5 RAJI cell mutant and untransfected L cells were completely resistant to SDCC. These results demonstrate that the MHC class II antigen is the target molecule in SDCC. HLA-DR molecules acted as receptors for SE and the complex was recognized by T lymphocytes in a polyclonal fashion. SDCC was mediated by allospecific cytotoxic CD8+ T cells, by cloned CD8+ T cells and by fresh human peripheral blood mononuclear cells. The SDCC phenomenon provides a rapid, potent and specific mechanism for elimination of HLA-DR+ target cells. We suggest that SDCC is an important combat strategy, employed by the bacteria to avoid specific MHC class II antigen-dependent immune recognition, by inducing T-cell dependent autologous lysis of MHC class II-expressing cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210803      PMCID: PMC1384227     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.

Authors:  H Fischer; M Dohlsten; M Lindvall; H O Sjögren; R Carlsson
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

Review 2.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

3.  An external stimulus that mimics Mls locus responses.

Authors:  C A Janeway; J Chalupny; P J Conrad; S Buxser
Journal:  J Immunogenet       Date:  1988 Feb-Jun

4.  Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes.

Authors:  M P Langford; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

5.  Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.

Authors:  M J Bevan; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

6.  Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells.

Authors:  R Carlsson; H Fischer; H O Sjögren
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

7.  Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

8.  Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies.

Authors:  M Dohlsten; G Hedlund; H O Sjögren; R Carlsson
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

9.  Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.

Authors:  R J van de Griend; M J Giphart; B A Van Krimpen; R L Bolhuis
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

10.  Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.

Authors:  D Wilkinson; R R de Vries; J A Madrigal; C B Lock; J P Morgenstern; J Trowsdale; D M Altmann
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  22 in total

1.  Mapping of staphylococcal enterotoxin A functional binding sites and presentation by monoclonal antibodies and fusion proteins.

Authors:  W Mahana
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.

Authors:  U Holzer; T Orlikowsky; C Zehrer; W Bethge; M Dohlsten; T Kalland; D Niethammer; G E Dannecker
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

3.  Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.

Authors:  P A Lando; G Hedlund; M Dohlsten; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.

Authors:  U Holzer; W Bethge; F Krull; J Ihle; R Handgretinger; R A Reisfeld; M Dohlsten; T Kalland; D Niethammer; G E Dannecker
Journal:  Cancer Immunol Immunother       Date:  1995-08       Impact factor: 6.968

6.  Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

Authors:  M Dohlsten; G Hedlund; E Akerblom; P A Lando; T Kalland
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

Authors:  P A Lando; M Dohlsten; G Hedlund; E Akerblom; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 8.  Monoclonal antibodies and superantigens: a novel therapeutic approach.

Authors:  T Kalland; M Dohlsten; P Lind; A Sundstedt; L Abrahmsén; G Hedlund; P Björk; P A Lando; M Björklund
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

9.  Superantigens anergize cytokine production but not cytotoxicity in vivo.

Authors:  A Sundstedt; M Dohlsten; G Hedlund; I Höidén; M Björklund; T Kalland
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

10.  T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.

Authors:  A Sundstedt; S Grundström; M Dohlsten
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.